| 國立臺灣大學 |
2009 |
Igf2bp3 (Imp3) Expression Is a Marker of Unfavorable Prognosis in Ovarian Carcinoma of Clear Cell Subtype
|
毛翠蓮; MAO, TSUI-LIEN |
| 臺大學術典藏 |
2020-03-05T12:32:54Z |
IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype
|
K?bel M.; Xu H.; Bourne P.A.; Spaulding B.O.; Shih I.-M.; TSUI-LIEN MAO; Soslow R.A.; Ewanowich C.A.; Kalloger S.E.; Mehl E.; Lee C.-H.; Huntsman D.; Gilks C.B. |
| 臺大學術典藏 |
2009 |
IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype
|
Köbel M.; Xu H.; Gilks C.B.; Bourne P.A.; Spaulding B.O.; Shih I.-M.; TSUI-LIEN MAO; Soslow R.A.; Ewanowich C.A.; Kalloger S.E.; Mehl E.; Lee C.-H.; Huntsman D. |
| 國立成功大學 |
2023-07-19 |
IGF2BP3-LSS傳遞途徑調控膽固醇合成促進肝癌細胞生長的重要角色
|
鄭亦宸; CHENG, YI-CHEN |
| 南台科技大學 |
1992-09 |
IGFBP-3 gene expression and estrogen receptor status in human breast carcinoma
|
陳健祺; J-C. Chen; Z-M. Shao; M. S. Sheikh; J. V. Ordonez; Pei Feng,;T. Kute; S. Aisner; L. Schnaper; D. LeRoith; C. T. Roberts; Jr.; J. Fontana |
| 國家衛生研究院 |
2006-04 |
IGFBP-3 suppresses tumor invasion through down regulation of ERK mitogen-activated protein kinases in ovarian endometrioid carcinoma
|
Torng, PL;Ye, JH;Huang, CYF;Cohen, P;Huang, SC;Lin, CT |
| 國立臺灣大學 |
2005 |
IGFBP-3 與卵巢癌侵入機制之研究
|
童寶玲 |
| 國立臺灣大學 |
2007 |
IGFBP-3基因表達在卵巢類子宮內膜腺癌中之分子調控機制
|
林敬瑋; Lin, Ching-Wei |
| 國立臺灣大學 |
2005 |
IGFBP-3基因表達在卵巢類子宮內膜腺癌中之功能分析
|
葉家宏; Ye, Jia-Hung |
| 國立臺灣大學 |
2010 |
IGFBP-3透過調控TSP-1的表現以抑制腫瘤的血管新生
|
施和均; Shih, Ho-Jun |
| 國家衛生研究院 |
2013-07-23 |
IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder
|
Liang, PI;Wang, YH;Wu, TF;Wu, WR;Liao, AC;Shen, KH;Hsing, CH;Shiue, YL;Huang, HY;Hsu, HP;Chen, LT;Lin, CY;Tai, C;Wu, JY;Li, CF |
| 國立成功大學 |
2013-07 |
IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder
|
Liang, Peir-In; Wang, Yu-Hui; Wu, Ting-Feng; Wu, Wen-Ren; Liao, Alex C.; Shen, Kun-Hung; Hsing, Chung-Hsi; Shiue, Yow-Ling; Huang, Hsuan-Ying; Hsu, Han-Ping; Chen, Li-Tzon; Lin, Ching-Yih; Tai, Chein; Wu, Jui-Yu; Li, Chien-Feng |
| 國立臺灣大學 |
2010 |
Igfbp-6 Plays a Role as an Oncosuppressor Gene in Npc Pathogenesis through Regulating Egr-1 Expression
|
郭源松; 湯月碧; 呂東盈; 吳漢忠; 林欽塘; KUO, YUAN-SUNG; TANG, YUEH-BIH; LU, TUNG-YING; WU, HAN-CHUNG; LIN, CHIN-TARNG |
| 臺大學術典藏 |
2022-03-04T06:10:53Z |
IGFBP-6 plays a role as an oncosuppressor gene in NPC pathogenesis through regulating EGR-1 expression
|
Kuo Y.-S.; Tang Y.-B.; Lu T.-Y.; Wu H.-C.; CHIN-TARNG LIN |
| 國立臺灣大學 |
2010 |
IGFBP-6經由調控EGR-1的表現在鼻咽癌細胞中扮演抑癌基因的角色
|
郭源松; Kuo, Yuan-Sung |
| 國家衛生研究院 |
2021-02 |
IGFBP3 promotes radiosensitivity of OSCC via appositive feedback of NF kappa B/IL-6/ROS signaling
|
Wang, SH;Chen, YL;Hsiao, JR;Tsai, FY;Jiang, SS;Lee, AYL;Tsai, HJ;Chen, YW |
| 國家衛生研究院 |
2024-03 |
IGFBP3 promotes radiosensitivity of OSCC via appositive feedback of NFkappaB/IL-6/ROS signaling
|
Wang, SH;Chen, YL;Huang, SH;Hsiao, JR;Tsai, FY;Jiang, SS;Tsai, HJ;Chen, YW |
| 國立成功大學 |
2024-03 |
IGFBP3 promotes radiosensitivity of OSCC via appositive feedback of NFκB/IL-6/ROS signaling
|
Wang;Ssu, H.;Chen;Yu, L.;Huang;Shih, H.;Hsiao;Jenn, R.;Tsai;Fang, Y.;Jiang;Shih, Shih S.;Tsai;Hui, J.;Chen;Ya, W. |
| 國家衛生研究院 |
2020 |
IGFBP3參與口腔癌放射治療的功能探討
|
陳雅雯;周秀專 |
| 臺大學術典藏 |
2020-03-06T05:26:02Z |
IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer
|
Wu S.-G.; Chang T.-H.; Tsai M.-F.; Liu Y.-N.; Hsu C.-L.; YIH-LEONG CHANG; Yu C.-J.; Shih J.-Y. |
| 臺大學術典藏 |
2020-03-07T06:56:11Z |
IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer
|
Tsai M.-F.; Liu Y.-N.; Hsu C.-L.; YIH-LEONG CHANG; Yu C.-J.; Shih J.-Y.; Wu S.-G.;Chang T.-H.;Tsai M.-F.;Liu Y.-N.;Hsu C.-L.;Yih-Leong Chang;Yu C.-J.;Shih J.-Y.; Wu S.-G.; Chang T.-H. |
| 臺大學術典藏 |
2020-08-12T08:25:19Z |
IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer
|
Shang-Gin Wu;Chang T.-H.;Tsai M.-F.;Liu Y.-N.;Hsu C.-L.;Chang Y.-L.;Yu C.-J.;Shih J.-Y.; SHANG-GIN WU; Chang T.-H.; Tsai M.-F.; Liu Y.-N.; Hsu C.-L.; Chang Y.-L.; Yu C.-J.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-13T06:33:29Z |
IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer
|
Hsu C.-L.; Liu Y.-N.; Tsai M.-F.; Chang T.-H.; Wu S.-G.; Wu S.-G.;Chang T.-H.;Tsai M.-F.;Liu Y.-N.;Hsu C.-L.;Chang Y.-L.;Yu C.-J.;Jin-Yuan Shih; Chang Y.-L.; Yu C.-J.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2021-09-15T01:20:52Z |
IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer
|
Wu S.-G.; Chang T.-H.; Tsai M.-F.; Liu Y.-N.; CHIA-LANG HSU; Chang Y.-L.; Yu C.-J.; Shih J.-Y. |
| 臺大學術典藏 |
2022-06-27T06:59:56Z |
IGFBP7 Drives resistance to epidermal growth factor receptor tyrosine kinase inhibition in lung cancer
|
Wu S.-G.; Chang T.-H.; Tsai M.-F.; Liu Y.-N.; Hsu C.-L.; Chang Y.-L.; CHONG-JEN YU; Shih J.-Y. |
